ArticleStatistics in medicine2026
Predicting Individual Risk of Advanced Adenoma Based on the Interval-Censored Recurrent Adenoma Event and Informative Screening Time.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Panel count data is common in cancer screening. In the context of colorectal cancer screening, our work focuses on the prediction of the probability of advanced adenoma conditional on patient-level risk factors and/or event history. We implement the joint frailty model proposed by Huang et al. which involves a non-stationary Poisson process for recurrent adenoma events and informative screening time using semi-parametric Cox models correlated by a latent frailty variable, where coefficients and baseline intensity functions are estimated by estimating equations. Subject-specific frailty value is estimated by the borrow-strength method. In addition, marginal models for the adenoma and screening events are also applicable when average covariate effects on the population level are of interest. Predictions based on the marginal model and predictions based on the frailty models for patients with or without a screening history are compared. When a patient's screening history is available and sufficient adenoma events are observed, the predictions based on the frailty model with estimated subject-specific frailty are superior. However, in the cases of early censoring when adenoma events are not observed for most patients and screening history is not available, the prediction based on the marginal model has better performance. Furthermore, for patients' future screening, the individualized screening intervals derived from the dynamic predictions of advanced adenoma risks will detect adenoma events earlier with shorter lag time between the adenoma state transition and the screening compared to the current practice of regular screening intervals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.